|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Contract revenue | |||||
| Grant revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Operating income/(loss) | |||||
| Other income/(expense): | |||||
| Gain/(loss) on deconsolidation of subsidiary | |||||
| Gain/(loss) on investments held at fair value | |||||
| Realized loss on sale of investments | |||||
| Realized gain/(loss) on sale of investments | |||||
| Gain/(loss) on investments in notes from associates | |||||
| Other income/(expense) | |||||
| Other income/(expense) | |||||
| Finance income/(costs): | |||||
| Finance income | |||||
| Finance costs – contractual | |||||
| Finance income/(costs) – fair value accounting | |||||
| Finance costs – non-cash interest expense related to sale of future royalties | |||||
| Net finance income/(costs) | |||||
| Share of net income/(loss) of associates accounted for using the equity method | |||||
| Gain/(loss) on dilution of ownership interest in associates | |||||
| Impairment of investment in associates | |||||
| Income/(loss) before taxes | |||||
| Tax benefit/(expense) | |||||
| Income/(loss) for the year | |||||
| Other comprehensive income/(loss): | |||||
| Equity-accounted associates – share of other comprehensive income/(loss) | |||||
| Reclassification of foreign currency differences on dilution of interest | |||||
| Total other comprehensive income/(loss) | |||||
| Total comprehensive income/(loss) for the year | |||||
| Income/(loss) attributable to: | |||||
| Owners of the Group | |||||
| Non-controlling interests | |||||
| Comprehensive income/(loss) attributable to: | |||||
| Owners of the Group | |||||
| Non-controlling interests | |||||
| Earnings/(loss) per share: | |||||
| Basic earnings/(loss) per share (in dollars per share) | |||||
| Diluted earnings/(loss) per share (in dollars per share) | |||||
Loading...